Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · IEX Real-Time Price · USD
130.23
+1.98 (1.54%)
At close: Mar 27, 2024, 4:00 PM
130.50
+0.27 (0.21%)
After-hours: Mar 27, 2024, 7:56 PM EDT

Sarepta Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1996
Net Income
-535.98-703.49-418.78-554.13-715.08-361.92-50.69-267.27-220.03-135.79
Upgrade
Depreciation & Amortization
58.8954.649.3439.7430.5512.258.095.615.253.69
Upgrade
Share-Based Compensation
182.51233.02113.94108.0778.650.1330.4729.9632.1220.35
Upgrade
Other Operating Activities
-206.4290.53-187.68513.79149.46-89.11-219.87-14.1333.2-16.79
Upgrade
Operating Cash Flow
-500.99-325.35-443.17107.47-456.46-388.66-232-245.82-149.47-128.54
Upgrade
Capital Expenditures
-76.11-30.82-38.49-82.2-59.63-61.16-12-5.34-3.4-25.44
Upgrade
Acquisitions
98-1100.2108.07-172.560125000
Upgrade
Change in Investments
-176.46-1,013.63436.01-144.09521.99-305.79-282.6-83.3313.24-132.21
Upgrade
Other Investing Activities
-11.24-1.43-2.31-3.5-3.08-3.54-9.22-1.53-1.43-1.38
Upgrade
Investing Cash Flow
-165.8-1,046.88495.41-121.72286.73-370.49-178.82-90.198.41-159.03
Upgrade
Share Issuance / Repurchase
51.2530.04569.33396.01401.96563.63369.18385.73119.9294.5
Upgrade
Debt Issued / Paid
0303.450291.11244.94-33.48569.8-7.617-0.09
Upgrade
Other Financing Activities
73.76-100.99-7.77-4.8-4.34--50.9-10.899.75
Upgrade
Financing Cash Flow
125232.51561.57682.32642.55530.15888.08378.13147.81104.16
Upgrade
Net Cash Flow
-541.79-1,139.72613.81668.07472.82-229477.2742.126.75-183.41
Upgrade
Free Cash Flow
-577.1-356.17-481.6625.26-516.09-449.82-244-251.16-152.87-153.98
Upgrade
Free Cash Flow Margin
-46.42%-38.17%-68.62%4.68%-135.52%-149.42%-157.84%-4633.11%-12200.00%-1578.18%
Upgrade
Free Cash Flow Per Share
-6.25-4.07-5.930.32-7.01-6.79-4.15-5.16-3.62-3.85
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).